Amdocs (NASDAQ:DOX) Issues Q4 2025 Earnings Guidance

Key Points

• Amdocs has issued Q4 2025 earnings guidance with an expected earnings per share of 1.790-1.850 and revenue guidance of $1.1 billion-$1.2 billion, both of which are slightly above analysts' estimates.
• As of the latest trading session, Amdocs shares have risen to $87.68, with a market capitalization of approximately $9.90 billion and a PE ratio of 18.58.
• Amdocs received mixed analyst ratings, with one report downgrading the stock from "buy" to "hold," while four analysts maintain a buy rating, resulting in a consensus rating of "Moderate Buy".

Amdocs (NASDAQ:DOX - Get Free Report) updated its fourth quarter 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 1.790-1.850 for the period, compared to the consensus earnings per share estimate of 1.823. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.1 billion. Amdocs also updated its FY 2025 guidance to 6.960-7.020 EPS.

Amdocs Price Performance

NASDAQ:DOX traded up $3.11 during trading hours on Thursday, reaching $87.68. The stock had a trading volume of 441,335 shares, compared to its average volume of 700,511. The stock has a market capitalization of $9.90 billion, a PE ratio of 18.58, a PEG ratio of 1.40 and a beta of 0.51. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.16 and a current ratio of 1.16. The company has a 50 day moving average price of $90.27 and a two-hundred day moving average price of $88.66. Amdocs has a 52 week low of $78.61 and a 52 week high of $95.41.

Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The technology company reported $1.72 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.01. Amdocs had a net margin of 11.39% and a return on equity of 19.52%. The firm had revenue of $1.14 billion for the quarter, compared to analysts' expectations of $1.13 billion. During the same quarter last year, the company earned $1.62 EPS. The firm's revenue for the quarter was down 8.4% compared to the same quarter last year. As a group, sell-side analysts anticipate that Amdocs will post 6.21 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts recently commented on DOX shares. Wolfe Research started coverage on shares of Amdocs in a research note on Tuesday, July 8th. They issued an "outperform" rating for the company. Wall Street Zen lowered Amdocs from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $105.33.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of DOX. Geneos Wealth Management Inc. lifted its position in shares of Amdocs by 213.9% in the 1st quarter. Geneos Wealth Management Inc. now owns 700 shares of the technology company's stock valued at $64,000 after acquiring an additional 477 shares in the last quarter. Empowered Funds LLC boosted its stake in shares of Amdocs by 12.0% in the 1st quarter. Empowered Funds LLC now owns 15,979 shares of the technology company's stock valued at $1,462,000 after purchasing an additional 1,709 shares in the last quarter. Amundi grew its position in Amdocs by 73.0% during the 1st quarter. Amundi now owns 13,778 shares of the technology company's stock worth $1,217,000 after acquiring an additional 5,816 shares during the last quarter. Goldman Sachs Group Inc. increased its holdings in shares of Amdocs by 12.6% in the first quarter. Goldman Sachs Group Inc. now owns 331,146 shares of the technology company's stock valued at $30,300,000 after purchasing an additional 37,087 shares in the last quarter. Finally, Millennium Management LLC raised its stake in shares of Amdocs by 458.3% during the first quarter. Millennium Management LLC now owns 67,047 shares of the technology company's stock worth $6,135,000 after buying an additional 55,038 shares during the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.